Alexa FluorARTM 488 anti-human CD183 (CXCR3) [G025H7] and 4 more items

BioLegend Inc. has been awarded a contract by the University of Virginia for the provision of specialized laboratory reagents and antibody products. The contract, designated A207_PO-0481103, was executed on September 16, 2026, with a total contract value of $642.00. The award encompasses five distinct line items consisting of fluorescently-labeled monoclonal antibodies designed for flow cytometry and immunological research applications, all to be delivered to Abhinav Arneja.

The contract deliverables include Alexa Fluor 488 anti-human CD183 (CXCR3) [G025H7] at $111.30; Brilliant Violet 421a anti-human CD122 (IL-2Rβ) [TU27] at $136.50; Brilliant Violet 711a anti-human CD45RO [UCHL1] at $162.00; PE anti-human CD95 (Fas) [DX2] at $90.30; and Brilliant Violet 421a anti-human CD95 (Fas) [DX2] at $142.50. These reagents are utilized in advanced immunophenotyping research and are representative of the specialized biological tools required by academic research institutions. The contract was issued in Virginia and represents a procurement of scientific materials by the University of Virginia's research operations.